Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies …

A Mathian, P Breillat, K Dorgham, P Bastard… - Annals of the …, 2022 - ard.bmj.com
Objectives Type-I interferons (IFNs-I) have potent antiviral effects. IFNs-I are also
overproduced in patients with systemic lupus erythematosus (SLE). Autoantibodies (AAbs) …
被引用次数：46 相关文章

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies …

A Mathian, P Breillat, K Dorgham… - Annals of the …, 2022 - search.proquest.com
Objectives Type-I interferons (IFNs-I) have potent antiviral effects. IFNs-I are also
overproduced in patients with systemic lupus erythematosus (SLE). Autoantibodies (AAbs) …
[PDF] researchgate.net

[PDF][PDF] Lower disease activity but higher risk of severe COVID-19 and herpes zoster in systemic lupus erythematosus patients with pre-existing autoantibodies …

SMM Mariaggi - researchgate.net
Abstract Objectives: Type-I interferons (IFNs-I) have potent antiviral effects. IFNs-I are also
overproduced in patients with systemic lupus erythematosus (SLE). Auto-antibodies (AAbs) …

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies …

A Mathian, P Breillat, K Dorgham… - Annals of the …, 2022 - pubmed.ncbi.nlm.nih.gov
Objectives Type-I interferons (IFNs-I) have potent antiviral effects. IFNs-I are also
overproduced in patients with systemic lupus erythematosus (SLE). Autoantibodies (AAbs) …

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in systemic lupus erythematosus patients with pre-existing autoantibodies neutralising …

A Mathian, P Breillat, K Dorgham… - Annals of the …, 2022 - hal.sorbonne-universite.fr
Objectives: Type-I interferons (IFNs-I) have potent antiviral effects. IFNs-I are also
overproduced in patients with systemic lupus erythematosus (SLE). Autoantibodies (AAbs) …

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in systemic lupus erythematosus patients with pre-existing autoantibodies neutralising …

A Mathian, P Breillat, K Dorgham, P Bastard… - Annals of the …, 2022 - hal.science
Objectives: Type-I interferons (IFNs-I) have potent antiviral effects. IFNs-I are also
overproduced in patients with systemic lupus erythematosus (SLE). Autoantibodies (AAbs) …
[PDF] bmj.com

[PDF][PDF] Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies …

A Mathian, P Breillat, K Dorgham, P Bastard… - Annals of the …, 2022 - ard.bmj.com
Objectives Type-I interferons (IFNs-I) have potent antiviral effects. IFNs-I are also
overproduced in patients with systemic lupus erythematosus (SLE). Autoantibodies (AAbs) …

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies …

A Mathian, P Breillat, K Dorgham, P Bastard… - Annals of the …, 2022 - europepmc.org
Objectives Type-I interferons (IFNs-I) have potent antiviral effects. IFNs-I are also
overproduced in patients with systemic lupus erythematosus (SLE). Autoantibodies (AAbs) …

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in systemic lupus erythematosus patients with pre-existing autoantibodies neutralising …

A Mathian, P Breillat, K Dorgham… - Annals of the …, 2022 - cnrs.hal.science
Objectives: Type-I interferons (IFNs-I) have potent antiviral effects. IFNs-I are also
overproduced in patients with systemic lupus erythematosus (SLE). Autoantibodies (AAbs) …

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in systemic lupus erythematosus patients with pre-existing autoantibodies neutralising …

A Mathian, P Breillat, K Dorgham, P Bastard… - Annals of the …, 2022 - hal.science
Objectives: Type-I interferons (IFNs-I) have potent antiviral effects. IFNs-I are also
overproduced in patients with systemic lupus erythematosus (SLE). Autoantibodies (AAbs) …